封面
市场调查报告书
商品编码
1477910

尿失禁治疗设备市场规模 - 按产品(尿道吊带、导管、电刺激装置、人工尿道括约肌)、失禁(压力、急迫、混合)、类别(内部、外部)、最终用途和预测,2024 - 2032 年

Urinary Incontinence Treatment Devices Market Size - By Product (Urethral Sling, Catheter, Electrical Stimulation Device, Artificial Urinary Sphincter), Incontinence (Stress, Urge, Mixed), Category (Internal, External), End-use & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

受全球人口老化、尿失禁治疗设备技术进步以及人们对尿失禁及其治疗方案认识不断提高的推动,2024-2032年全球尿失禁治疗设备市场将以8.6%的复合年增长率成长。

由于人口老化、生活方式改变和慢性疾病增加等因素,数百万人受到尿失禁的影响,对先进治疗解决方案的需求正在增加。根据 Medscape Emedicine 的数据,经常被忽视和低估的尿失禁随着年龄的增长而变得更加普遍,影响了 38-55% 的 60 岁以上女性和 50-84% 的长期护理机构老年居民。盛行率的激增,加上人们对尿失禁及其併发症的认识不断提高,正在推动创新治疗设备的开发和采用。

人们正在寻求技术进步,包括微创手术和穿戴式解决方案,以满足不同的患者需求。医疗保健提供者、研究机构和製造商之间的合作正在进一步提高治疗效果。在有利的报销政策和政府措施的支持下,尿失禁治疗设备市场有望大幅扩张,为全球受影响的个人提供更好的生活品质。

尿失禁治疗设备市场根据最终用户、产品类型、类别、失禁和地区进行分类。

导管细分市场将在 2024 年至 2032 年期间获得值得称讚的牵引力,因为导管透过促进膀胱排空在控制尿失禁方面发挥至关重要的作用。随着技术的进步,导管变得更加先进,提供抗菌涂层和改进材料等功能,以提高患者舒适度并降低感染风险,从而促进导管段的成长。

到 2032 年,终端用户领域的诊所将以显着的复合年增长率扩张,因为诊所为尿失禁患者提供专门护理和广泛的治疗选择。门诊手术的便利性和诊所熟练的医疗保健专业人员的可用性使它们成为许多寻求尿失禁治疗的患者的首选。

在中国、印度和日本等国家快速城市化、医疗基础设施投资增加以及人口老化日益严重的推动下,亚太地区尿失禁治疗设备产业将在 2032 年显着扩张。此外,人们对尿失禁的认识不断提高,医疗保健服务的普及预计将进一步推动该地区的产品需求。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 尿失禁(UI)盛行率增加
      • 设备和手术技术的技术进步
      • 摄护腺癌发生率不断上升
    • 产业陷阱与挑战
      • 程序成本高
      • 与手术相关的风险和併发症
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 定价分析
  • 未来市场趋势
  • 报销场景

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 尿道吊带
    • 男吊带
    • 女性/阴道吊带
      • 经闭孔吊带
      • 无张力阴道吊带
      • 迷你吊带
  • 导尿管
    • 留置导管
    • 间歇导管
    • 外部导管
  • 电刺激装置
  • 人工尿道括约肌
  • 其他产品

第 6 章:市场估计与预测:按失禁类型,2018 年 - 2032 年

  • 主要趋势
  • 压力
  • 敦促
  • 混合
  • 其他失禁类型

第 7 章:市场估计与预测:按类别,2018 - 2032

  • 主要趋势
  • 内部失禁装置
  • 外部失禁装置

第 8 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他最终用户

第 9 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • B Braun Melsungen AG
  • Caldera Medical Inc.
  • Coloplast A/S
  • ConvaTec Group plc
  • Hollister Incorporated
  • Medtronic plc
  • PROMEDON GmbH
  • Teleflex Incorporated
  • Zephyr Surgical Implants
简介目录
Product Code: 8190

Global Urinary Incontinence Treatment Devices Market will grow at 8.6% CAGR during 2024-2032, driven by the growing aging population worldwide, technological advancements in urinary incontinence treatment devices, and rising awareness about urinary incontinence and its treatment options.

With millions affected by urinary incontinence disorders attributed to factors like aging demographics, lifestyle changes, and rising chronic diseases, the demand for advanced treatment solutions is on the rise. As per Medscape Emedicine, urinary incontinence, often overlooked and underreported, becomes more prevalent with age, impacting 38-55% of women over 60 and 50-84% of elderly residents in long-term care facilities. This surge in prevalence, coupled with growing awareness about urinary incontinence and its complications, is fueling the development and adoption of innovative treatment devices.

Technological advancements, including minimally invasive procedures and wearable solutions, are being pursued to address diverse patient needs. Collaborative efforts between healthcare providers, research institutions, and manufacturers are further enhancing treatment efficacy. Supported by favorable reimbursement policies and government initiatives, the urinary incontinence treatment devices market is poised for significant expansion, offering improved quality of life for affected individuals worldwide.

The Urinary Incontinence Treatment Devices Market is classified based on end-user, product type, category, incontinence, and region.

The catheters segment will gain commendable traction over 2024-2032, as catheters play a vital role in managing urinary incontinence by facilitating the emptying of the bladder. With technological advancements, catheters have become more advanced, offering features such as anti-microbial coatings and improved materials for enhanced patient comfort and reduced risk of infection, thereby inducing segment growth.

Clinics from the end-user segment will expand at a noteworthy CAGR through 2032 as clinics offer specialized care and access to a wide range of treatment options for patients suffering from urinary incontinence. The convenience of outpatient procedures and the availability of skilled healthcare professionals in clinics make them a preferred choice for many patients seeking treatment for urinary incontinence.

Asia Pacific Urinary Incontinence Treatment Devices Industry will expand notably by 2032, driven by rapid urbanization, increasing healthcare infrastructure investments, and a growing aging population in countries such as China, India, and Japan. Moreover, rising awareness about urinary incontinence and improving access to healthcare services is expected to further boost product demand in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
      • 3.2.1.2 Technological advancements in devices and surgical techniques
      • 3.2.1.3 Growing incidence of prostate cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedural cost
      • 3.2.2.2 Risks and complications associated with the procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Pricing analysis
  • 3.9 Future market trends
  • 3.10 Reimbursement scenario

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Urethral slings
    • 5.2.1 Male slings
    • 5.2.2 Female/vaginal slings
      • 5.2.2.1 Transobturator slings
      • 5.2.2.2 Tension-free vaginal tape slings
      • 5.2.2.3 Mini-slings
  • 5.3 Urinary catheters
    • 5.3.1 Indwelling catheters
    • 5.3.2 Intermittent catheters
    • 5.3.3 External catheters
  • 5.4 Electrical stimulation devices
  • 5.5 Artificial urinary sphincters
  • 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stress
  • 6.3 Urge
  • 6.4 Mixed
  • 6.5 Other incontinence type

Chapter 7 Market Estimates and Forecast, By Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Internal incontinence devices
  • 7.3 External incontinence devices

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Boston Scientific Corporation
  • 10.3 B Braun Melsungen AG
  • 10.4 Caldera Medical Inc.
  • 10.5 Coloplast A/S
  • 10.6 ConvaTec Group plc
  • 10.7 Hollister Incorporated
  • 10.8 Medtronic plc
  • 10.9 PROMEDON GmbH
  • 10.10 Teleflex Incorporated
  • 10.11 Zephyr Surgical Implants